RELATED CONTENT
NEWS
- Eisai mulls NICE appeal after another no for Halaven
- Adverse effects cast doubt over Sanofi's Taxotere follow on Jevtana, says NICE
- Roche pins Tarceva hope on Cancer Drugs Fund after NICE rejects appeal
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

